Impact of coexpression and coamplification of sICAM and antiapoptosis determinants bcl-2/bcl-x(L) on productivity,cell survival,and mitochondria number in CHO-DG44 grown in suspension and serum-free media

We have engineered dihydrofolate reductase-negative (dhfr-/-) Chinese hamster ovary (CHO) DG44 cells adapted for growth in serum-free suspension cultures for simultaneous expression of the common cold therapeutic, the soluble intercellular adhesion molecule 1 (sICAM), and the antiapoptosis determinants bcl-2 or bcl-x(L). Detailed analyses of titer and antiapoptosis characteristics of these production cell lines included an independent (sICAM; bcl-2/bcl-x(L)) as well as a cocistronic (sICAM-(bcl-2/bcl-x(L))) expression set-up in which translation-initiation of the survival cistron is driven by an internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV). In transient transfections or stable mixed populations and in comparison to isogenic sICAM-only control vectors, both bcl-x(L)-encoding configurations achieved higher sICAM yields while bcl-2 over-expression resulted in decreased product levels. Overall, the death-protective impact of bcl-2 and bcl-x(L) in engineered CHO-DG44 was not significant under typical batch-mode operation, an observation that was confirmed by clonal analysis. bcl-2 and bcl-x(L) displayed their antiapoptosis potential only following dhfr-based amplification in sICAM-producing CHO-DG44 cell lines. In all cases, bcl-x(L) outperformed bcl-2 in its cell death-protective capacity. Amplification-dependent high-level expression of mitochondria-localized bcl-2 family members required for successful antiapoptosis engineering may be essential to compensate for increased mitochondria numbers found to be associated with production cell lines grown in serum-free medium.     

低氧时一氧化碳对PASMC增殖的影响及机制探讨

目的和方法 :应用MTT比色、原位杂交、免疫细胞化学技术检测内源性或外源性CO对低氧状态下PASMC增殖的作用以及对PDGF B和原癌基因bcl 2、突变型p5 3表达的影响 ,探讨CO抑制低氧状态下PASMC增殖的机制。结果 :各组PASMC中PDGF BmRNA原位杂交和PDGF B蛋白的免疫细胞化学染色均为阴性 ,单纯低氧组较正常对照组Bcl 2和突变型P5 3蛋白表达增强 (P <0 .0 1) ,Hemin和CO干预组Bcl 2和突变型P5 3蛋白表达低于单纯低氧组 ,而Hb干预组则高于单纯低氧组 (P <0 .0 1)。结论 :低氧时CO可能通过抑制Bcl 2和突变型P5 3的表达而抑制PASMC的增殖     

Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide

Cell culture, tissue chemistry and flow cytometry were used to determine whether antisense bcl-2 oligodeoxynucleotides enhanced the sensitivity of leukemia cells to arsenic trioxide. A combination of arsenic trioxide with antisense bcl-2 oligodeoxynucleotides inhibited cell growth, induced apoptosis and induced bcl-2 protein expression in K562 and NB4 leukemic cells more significantly than either arsenic trioxide or the oligodeoxynucleotides on their own (P<0.01). Thus, bcl-2 antisense oligodeoxynucleotides increase the sensitivity of leukemic cells to arsenic trioxide. Combined use of the two agents could be a novel and attractive strategy in leukemia treatment.     

细胞凋亡过程中bcl-2基因的甲基化

为探讨凋亡过程中,ｂｃｌ－２基因下调与该基因甲基化状态的关系,用５－氟尿嘧啶（５－Ｆｕ）诱导小鼠成纤维细胞ＮＣ３Ｈ１０,ＴＣ３Ｈ１０及人乳腺癌细胞ＭＣＦ－７的凋亡,分别检测了这三种细胞凋亡过程中ｂｃｌ－２的表达变化,与其调控区及编码区的甲基化状况．我们曾观察到５－Ｆｕ作用２４～４８ｈ出现细胞存活率下降,ＤＮＡ梯状断裂及细胞周期凋亡峰显现等典型凋亡现象．Ｎｏｒｔｈｅｒｎ杂交显示,在５－Ｆｕ作用１２ｈ时ｂｃｌ－２ｍＲＮＡ水平已明显降低．由此,我们用小鼠ｂｃｌ－２（ｍｂｃｌ－２）及人ｂｃｌ－２（ｈｂｃｌ－２）基因调控区ＰＣＲ扩增片段及ｂｃｌ－２编码区（ｃＤＮＡ）片段作为探针,与５－Ｆｕ作用１２ｈ的细胞ＤＮＡ的ＭｓｐⅠ／ＨｐａⅡ酶切产物进行Ｓｏｕｔｈｅｒｎ杂交,以未作用的细胞ＤＮＡ同样酶切杂交为对照．通过杂交带谱的变化,分析ｂｃｌ－２基因的甲基化状况．结果显示：ｍｂｃｌ－２及ｈｂｃｌ－２在５－Ｆｕ作用１２ｈ后调控区甲基化水平增高,但其编码区甲基化状态皆未出现可检出的变化．上述结果提示：ｂｃｌ－２基因调控区甲基化水平升高可能与该基因下调有关     

小鼠成纤维细胞凋亡过程中P53与bcl-2表达的时序性

为探讨细胞凋亡过程中,ｂｃｌ－２与Ｐ５３,这两种凋亡关键性基因的相互关系,用５－氟尿嘧啶（５－Ｆｕ）诱导小鼠正常与恶性转化的成纤维细胞的凋亡,观察了这两种基因在凋亡过程中表达变化的时序．经流式细胞计检测,这两种细胞在５－Ｆｕ作用２４ｈ均出现了凋亡峰,细胞存活率随之下降,ＤＮＡ电泳显现梯状断裂．Ｎｏｒｔｈｅｒｎ杂交结果显示,在５－Ｆｕ作用６ｈ后两种细胞Ｐ５３ｍＲＮＡ水平已明显增高,而ｂｃｌ－２ｍＲＮＡ水平则在作用１２ｈ方明显降低．Ｐ５３上调与ｂｃｌ－２下调的明显时序性,说明Ｐ５３具备作为ｂｃｌ－２基因负调控转录因子的条件．由此,为进一步了解凋亡过程的ｂｃｌ－２基因下调机理提供了线索     

MicroRNA‐181c targets Bcl‐2 and regulates mitochondrial morphology in myocardial cells

Apoptosis is an important mechanism for the development of heart failure. Mitochondria are central to the execution of apoptosis in the intrinsic pathway. The main regulator of mitochondrial pathway of apoptosis is Bcl‐2 family which includes pro‐ and anti‐apoptotic proteins. MicroRNAs are small noncoding RNA molecules that regulate gene expression by inhibiting mRNA translation and/or inducing mRNA degradation. It has been proposed that microRNAs play critical roles in the cardiovascular physiology and pathogenesis of cardiovascular diseases. Our previous study has found that microRNA‐181c, a miRNA expressed in the myocardial cells, plays an important role in the development of heart failure. With bioinformatics analysis, we predicted that miR‐181c could target the 3′ untranslated region of Bcl‐2, one of the anti‐apoptotic members of the Bcl‐2 family. Thus, we have suggested that miR‐181c was involved in regulation of Bcl‐2. In this study, we investigated this hypothesis using the Dual‐Luciferase Reporter Assay System. Cultured myocardial cells were transfected with the mimic or inhibitor of miR‐181c. We found that the level of miR‐181c was inversely correlated with the Bcl‐2 protein level and that transfection of myocardial cells with the mimic or inhibitor of miR‐181c resulted in significant changes in the levels of caspases, Bcl‐2 and cytochrome C in these cells. The increased level of Bcl‐2 caused by the decrease in miR‐181c protected mitochondrial morphology from the tumour necrosis factor alpha‐induced apoptosis.     

Lead-induced alterations of apoptosis and neurotrophic factor mRNA in the developing rat cortex, hippocampus, and cerebellum

Previous reports have recently shown the prototypic neurotoxicant, lead, to induce apoptosis in the brains of developing organisms. In the current study, timed-pregnant rats were exposed to lead acetate (0.2% in the drinking water) 24 h following birth at postnatal day 1 (PND 1). Dams and pups were continuously exposed to lead through the drinking water of the dam until PND 20. Postnatal exposure in the pups resulted in altered mRNA levels of the following apoptotic and neurotrophic factors: caspase 2 and 3, bax, bcl-x, brain-derived neurotrophic factor (BDNF). Ribonuclease protection assays were conducted to measure the factors simultaneously at the following postnatal time points: 9, 12, 15, 20, 25, days. Our results suggest a brain region- and time-specific response following lead acetate exposure. The region most vulnerable to alterations occurs in the hippocampus with alterations beginning at PND 12, in which caspase 3, bcl-x, BDNF increase with lead exposure. Significant treatment effects were not observed for both the cortex and cerebellum.     

Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma

We recently reported that bcl-xL regulates interleukin 8 (CXCL8) protein expression and promoter activity in glioblastoma cells. In this paper we demonstrate that CXCL8 induction by bcl-xL is mediated through a nuclear factor-kappa B (NF-kB)-dependent mechanism. Mutational studies on the CXCL8 promoter showed that NF-kB binding site was required for bcl-xL-induced promoter activity and an enhanced nuclear expression of NF-kB subunits p65 and p50 was observed after bcl-xL over-expression. Electrophoretic mobility shift assay showed an increased DNA-binding activity of NF-kB in bcl-xL over-expressing cells and the use of specific antibodies confirmed the involvement of p65 and p50 in NF-kB activity on CXCL8 promoter sequence. NF-kB activity regulation by bcl-xL involved IkBalpha and IKK complex signaling pathway. In fact, bcl-xL over-expression induced a decrease of cytoplasmic expression of the IkBalpha protein, paralleled by an increase in the phosphorylation of the same IkBalpha and IKKalpha/beta. Moreover, the down-regulation of the ectopic or endogenous bcl-xL expression through RNA interference confirmed the ability of bcl-xL to modulate NF-kB pathway, and the transient expression of a degradation-resistant form of the cytoplasmic NF-kB inhibitor IkBalpha in bcl-xL transfectants confirmed the involvement of that inhibitor in bcl-xL-induced CXCL8 expression and promoter activity. In conclusion, our results demonstrate the role of NF-kB as the mediator of bcl-xL-induced CXCL8 up-regulation in glioblastoma cells.     

Bcl-2在去甲二氢愈创木酸诱导恶性胶质瘤细胞凋亡中的变化

观察bcl-2在去甲二氢愈创木酸（NDGA）诱导恶性胶质瘤细胞系SHG-44细胞凋亡中的变化。利用光镜和电镜观察及TUNEL法检测培养细胞凋亡的情况。用免疫组织化学,原位杂交和图像分析等方法检测bcl-2基因mRNA和蛋白的表达水平。结果显示：（1）一定浓度的NDGA处理SHG-44细胞12-96h,均可诱导SHG-44细胞发生凋亡,且随着作用时间的延长,凋亡细胞数增加越明显;（2）免疫组织化学方法结果显示,NDGA处理细胞后,出现SHG-44细胞bcl-2蛋白表达水平降低,且随着作用时间的延长,这种趋势更加明显,与细胞凋亡的发生密切相关;（3）原位杂交结果显示,NDGA处理细胞不同时间后,出现SHG-44细胞bcl-2基因mRNA的表达水平降低,结果与免疫组织化学方法检测结果一致,上述结果表明,NDGA诱导SHG-44细胞凋亡过程中,bcl-2基因的表达降低,但其确切机制有待进一步深入研究。     

光化学法脑缺血后细胞凋亡及其相关基因bcl-2表达的变化

采用ＴＵＮＥＬ染色及免疫组织化学技术对光化学法脑缺血后细胞凋亡及其相关基因ｂｃｌ－２表达的变化进行了研究。结果发现，缺血后１２ｈ，损伤侧皮层缺血区内凋亡细胞数及ｂｃｌ－２免疫反应阳性细胞数明显增加，一直持续至缺血后７２ｈ；并呈现下列时程变化：在缺血后３ｈ每张切片上几乎无凋亡细胞出现，以后逐渐增加，缺血后１２ｈ达到峰值，缺血后２４ｈ和缺血后７２ｈ逐渐减少，但仍高于假手术组水平。凋亡相关基因ｂｃｌ－２的表达在缺血后３ｈ以前不明显，缺血后１２ｈ逐渐增加，缺血后２４ｈ最多，以后逐渐下降。上述结果提示，缺血后凋亡细胞的时程变化可能与缺血后梗塞灶的发生和发展有关，而ｂｃｌ－２表达的变化可能与抑制细胞凋亡、发挥内源性细胞保护作用有关。